Item 2. Unregistered Sales of Equity Securities
Item 2. Unregistered
Sales of Equity Securities and Use of Proceeds.
On
December 27, 2022, we executed a securities purchase agreement with a single investor to sell, as a purchase price of $1.12 per share,
135,000 common shares and warrants to purchase 135,000 common shares, with an exercise price of $1.12 per share and a term of three years.
The warrants will be exercisable upon the later of six months from their issuance date, or until we increase our authorized shares. In
addition, the purchaser agreed to execute a proxy permitting our Chief Executive Officer and Chief Financial Officer to vote the securities
purchased in favor of any shareholder vote relating to a future increase of our authorized shares. Pursuant to the securities purchase
agreement, we agreed to hold a meeting of shareholders within 200 days of the execution of the securities purchase agreement for the purpose
of increasing our authorized shares.
The
aforementioned securities issued are exempt from the registration requirements of the Securities Act of 1933, as amended, or the Securities
Act, pursuant to Section 4(a)(2) of the Securities Act and/or Rule 506(b) of Regulation D and Regulation S promulgated thereunder. The
securities have not been registered under the Securities Act and may not be sold in the United States absent registration or an exemption
from registration.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.